Cosmos Health Q3 2025 revenue $17.1M (+38% YoY), record gross margin 15.2%, cash jumps to $4.63M

Cosmos Health Inc.

2025-Q3 EPS reported -$0.32 revenue$45,568,655

Q3 2025 revenue $17.11M (up 38% YoY); gross profit $2.60M (+116%), gross margin 15.21% (vs 9.72%).
Adjusted EBITDA loss narrowed 74% to ($0.19M); adjusted EPS $(0.02) vs $(0.34) a year ago.
Cash and cash equivalents surged to $4.63M from $0.66M at June 30, 2025.
Secured $300M digital financing facility and commenced Ethereum purchases.
Contract manufacturing agreement for 3M MYCOFAGYL pessaries annually; Sky Premium Life enters Oman.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.